Parathyroid Disease Treatment Global Market Report 2025

Description

Parathyroid disease treatment involves medical and surgical methods aimed at managing disorders of the parathyroid glands, small endocrine glands in the neck responsible for regulating calcium and phosphorus levels in the body by secreting parathyroid hormone (PTH).

The primary treatment options for parathyroid disease include calcimimetics, bisphosphonates, plicamycin, hormone replacement therapy, and other therapies. Calcimimetics are medications that lower parathyroid hormone (PTH) levels by mimicking calcium and stimulating calcium-sensing receptors on the parathyroid glands. These drugs can be administered orally or parenterally and are distributed through hospital pharmacies, online pharmacies, and retail pharmacies. They are utilized by a range of end-users, including hospitals, homecare settings, specialty centers, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The parathyroid disease treatment market research report is one of a series of new reports from The Business Research Company that provides parathyroid disease treatment market statistics, including the parathyroid disease treatment industry global market size, regional shares, competitors with the parathyroid disease treatment market share, detailed parathyroid disease treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the parathyroid disease treatment industry. These parathyroid disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The parathyroid disease treatment market size has grown strongly in recent years. It will grow from $2.21 billion in 2024 to $2.37 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth during the historic period can be attributed to the rising prevalence of chronic kidney disease, increasing cases of osteoporosis, heightened awareness of endocrine disorders, expansion of diagnostic capabilities, and improved access to specialty healthcare.

The parathyroid disease treatment market size is expected to see strong growth in the next few years. It will grow to $3.10 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The projected growth in the forecast period can be linked to the increasing aging population, greater use of non-surgical treatments, a rising incidence of postmenopausal bone disorders, government initiatives targeting rare disease management, and wider adoption of minimally invasive parathyroidectomy. Key trends expected during this time include a move toward personalized hormone therapies, development of long-acting hormone analogs, incorporation of AI in endocrine diagnostics, focus on drugs targeting calcium-sensing receptors, and advancements in parathyroid hormone analogs.

The increasing prevalence of chronic kidney disease (CKD) is expected to drive growth in the parathyroid disease treatment market. CKD is a progressive condition where kidney function declines over time, causing mineral imbalances like calcium and phosphorus. This rise in CKD cases is largely attributed to the growing incidence of diabetes, as prolonged high blood sugar levels can damage the kidneys' filtering units, leading to diabetic nephropathy. Treating parathyroid disease is crucial for managing CKD, particularly to address secondary hyperparathyroidism, a common complication in advanced CKD that disrupts mineral balance, contributes to bone disorders, and causes vascular calcification. For example, in June 2024, the Australian Institute of Health and Welfare reported that CKD mortality rates increased by 4.2% in 2021 and 6.2% in 2022. In 2022, CKD was responsible for approximately 22,000 deaths, accounting for 11% of all deaths in Australia, with a mortality rate of 84 per 100,000 people. Hence, the growing prevalence of CKD is fueling the parathyroid disease treatment market.

Companies in the parathyroid disease treatment market are advancing hormone replacement therapies by developing parathyroid hormone prodrugs that improve calcium regulation and reduce dosing frequency for hypoparathyroidism patients. Parathyroid hormone (PTH) prodrugs are inactive compounds that activate in the body to help maintain calcium and phosphate balance. For instance, in August 2024, Ascendis Pharma A/S, a Denmark-based biopharmaceutical firm, received FDA approval for YORVIPATH (palopegteriparatide), a PTH prodrug for treating chronic hypoparathyroidism in adults. This once-daily treatment offers continuous hormone exposure over 24 hours, providing an alternative to traditional calcium and vitamin D supplements by directly addressing hormone deficiency. The approval of YORVIPATH highlights the growing focus on innovative hormone replacement therapies to improve treatment adherence and clinical outcomes for patients with parathyroid disorders.

In July 2024, AstraZeneca PLC, a UK-based biopharmaceutical company, acquired Amolyt Pharma SAS for $1.05 billion. This acquisition is intended to enhance AstraZeneca's Alexion Rare Disease portfolio by advancing its late-stage pipeline and expanding its bone metabolism franchise with eneboparatide (AZP-3601), a Phase III investigational drug for hypoparathyroidism treatment. Amolyt Pharma SAS is a France-based clinical-stage biotech company specializing in developing novel therapies for rare endocrine diseases, including parathyroid disorders such as hypoparathyroidism.

Major players in the parathyroid disease treatment market are AstraZeneca PLC, Amgen Inc., Teijin Pharma Limited, Kyowa Kirin Co. Ltd., Shandong Buchang Pharmaceuticals Co. Ltd., OPKO Health Inc., Septerna Inc., Entera Bio Ltd., Visen Pharmaceuticals (Shanghai) Co. Ltd., Ascendis Pharma A/S, Aeterna Zentaris Inc., MBX Biosciences Inc., STERIS Healthcare Private Limited, Crinetics Pharmaceuticals Inc., Amorphical Ltd., Vidasym Inc., Extend Biosciences Inc., Rani Therapeutics LLC, Pathalys Pharma Inc., and ProLynx LLC.

Asia-Pacific was the largest region in the parathyroid disease treatment market in 2024. The regions covered in parathyroid disease treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the parathyroid disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The parathyroid disease treatment market consists of revenues earned by entities by providing services such as diagnostic testing, surgical intervention, hormone level monitoring, post-operative care, and medical management of calcium and phosphate balance. The market value includes the value of related goods sold by the service provider or included within the service offering. The parathyroid disease treatment market also includes sales of lanthanum carbonate, doxercalciferol, calcitriol, lanthanum carbonate, and parsabiv. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Parathyroid Disease Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on parathyroid disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for parathyroid disease treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The parathyroid disease treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Treatment: Calcimimetics; Bisphosphonates; Plicamycin; Hormone Replacement Therapy; Other Treatments
2) By Route Of Administration: Oral; Parenteral
3) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
4) By End-Users: Hospitals; Homecare; Specialty Centers; Other End-Users
Subsegments:
1) By Calcimimetics: Cinacalcet; Etelcalcetide
2) By Bisphosphonates: Alendronate; Ibandronate; Risedronate; Zoledronic Acid
3) By Plicamycin: Mithramycin (Plicamycin) Monotherapy; Combination Therapies Involving Plicamycin
4) By Hormone Replacement Therapy: Estrogen Therapy; Progesterone Therapy; Combined Hormonal Therapies; Selective Estrogen Receptor Modulators (SERMs)
5) By Other Treatments: Parathyroid Hormone (PTH) Analogues; Surgery (Parathyroidectomy); Dietary Supplements; Lifestyle And Nutritional Interventions
Companies Mentioned: AstraZeneca PLC; Amgen Inc.; Teijin Pharma Limited; Kyowa Kirin Co. Ltd.; Shandong Buchang Pharmaceuticals Co. Ltd.; OPKO Health Inc.; Septerna Inc.; Entera Bio Ltd.; Visen Pharmaceuticals (Shanghai) Co. Ltd.; Ascendis Pharma A/S; Aeterna Zentaris Inc.; MBX Biosciences Inc.; STERIS Healthcare Private Limited (subsidiary of STERIS plc); Crinetics Pharmaceuticals Inc.; Amorphical Ltd.; Vidasym Inc.; Extend Biosciences Inc.; Rani Therapeutics LLC; Pathalys Pharma Inc.; ProLynx LLC.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r37095

1. Executive Summary

2. Parathyroid Disease Treatment Market Characteristics

3. Parathyroid Disease Treatment Market Trends And Strategies

4. Parathyroid Disease Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Parathyroid Disease Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Parathyroid Disease Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Parathyroid Disease Treatment Market Growth Rate Analysis
5.4. Global Parathyroid Disease Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Parathyroid Disease Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Parathyroid Disease Treatment Total Addressable Market (TAM)

6. Parathyroid Disease Treatment Market Segmentation

6.1. Global Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Calcimimetics
Bisphosphonates
Plicamycin
Hormone Replacement Therapy
Other Treatments
6.2. Global Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Parenteral
6.3. Global Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
6.4. Global Parathyroid Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Homecare
Specialty Centers
Other End-Users
6.5. Global Parathyroid Disease Treatment Market, Sub-Segmentation Of Calcimimetics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cinacalcet
Etelcalcetide
6.6. Global Parathyroid Disease Treatment Market, Sub-Segmentation Of Bisphosphonates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Alendronate
Ibandronate
Risedronate
Zoledronic Acid
6.7. Global Parathyroid Disease Treatment Market, Sub-Segmentation Of Plicamycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mithramycin (Plicamycin) Monotherapy
Combination Therapies Involving Plicamycin
6.8. Global Parathyroid Disease Treatment Market, Sub-Segmentation Of Hormone Replacement Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Estrogen Therapy
Progesterone Therapy
Combined Hormonal Therapies
Selective Estrogen Receptor Modulators (SERMs)
6.9. Global Parathyroid Disease Treatment Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Parathyroid Hormone (PTH) Analogues
Surgery (Parathyroidectomy)
Dietary Supplements
Lifestyle And Nutritional Interventions

7. Parathyroid Disease Treatment Market Regional And Country Analysis

7.1. Global Parathyroid Disease Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Parathyroid Disease Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Parathyroid Disease Treatment Market

8.1. Asia-Pacific Parathyroid Disease Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Parathyroid Disease Treatment Market

9.1. China Parathyroid Disease Treatment Market Overview
9.2. China Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Parathyroid Disease Treatment Market

10.1. India Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Parathyroid Disease Treatment Market

11.1. Japan Parathyroid Disease Treatment Market Overview
11.2. Japan Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Parathyroid Disease Treatment Market

12.1. Australia Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Parathyroid Disease Treatment Market

13.1. Indonesia Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Parathyroid Disease Treatment Market

14.1. South Korea Parathyroid Disease Treatment Market Overview
14.2. South Korea Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Parathyroid Disease Treatment Market

15.1. Western Europe Parathyroid Disease Treatment Market Overview
15.2. Western Europe Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Parathyroid Disease Treatment Market

16.1. UK Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Parathyroid Disease Treatment Market

17.1. Germany Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Parathyroid Disease Treatment Market

18.1. France Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Parathyroid Disease Treatment Market

19.1. Italy Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Parathyroid Disease Treatment Market

20.1. Spain Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Parathyroid Disease Treatment Market

21.1. Eastern Europe Parathyroid Disease Treatment Market Overview
21.2. Eastern Europe Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Parathyroid Disease Treatment Market

22.1. Russia Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Parathyroid Disease Treatment Market

23.1. North America Parathyroid Disease Treatment Market Overview
23.2. North America Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Parathyroid Disease Treatment Market

24.1. USA Parathyroid Disease Treatment Market Overview
24.2. USA Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Parathyroid Disease Treatment Market

25.1. Canada Parathyroid Disease Treatment Market Overview
25.2. Canada Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Parathyroid Disease Treatment Market

26.1. South America Parathyroid Disease Treatment Market Overview
26.2. South America Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Parathyroid Disease Treatment Market

27.1. Brazil Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Parathyroid Disease Treatment Market

28.1. Middle East Parathyroid Disease Treatment Market Overview
28.2. Middle East Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Parathyroid Disease Treatment Market

29.1. Africa Parathyroid Disease Treatment Market Overview
29.2. Africa Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Parathyroid Disease Treatment Market Competitive Landscape And Company Profiles

30.1. Parathyroid Disease Treatment Market Competitive Landscape
30.2. Parathyroid Disease Treatment Market Company Profiles
- 30.2.1. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Teijin Pharma Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Kyowa Kirin Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Shandong Buchang Pharmaceuticals Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Parathyroid Disease Treatment Market Other Major And Innovative Companies

31.1. OPKO Health Inc.
31.2. Septerna Inc.
31.3. Entera Bio Ltd.
31.4. Visen Pharmaceuticals (Shanghai) Co. Ltd.
31.5. Ascendis Pharma A/S
31.6. Aeterna Zentaris Inc.
31.7. MBX Biosciences Inc.
31.8. STERIS Healthcare Private Limited
31.9. Crinetics Pharmaceuticals Inc.
31.10. Amorphical Ltd.
31.11. Vidasym Inc.
31.12. Extend Biosciences Inc.
31.13. Rani Therapeutics LLC
31.14. Pathalys Pharma Inc.
31.15. ProLynx LLC

32. Global Parathyroid Disease Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Parathyroid Disease Treatment Market

34. Recent Developments In The Parathyroid Disease Treatment Market

35. Parathyroid Disease Treatment Market High Potential Countries, Segments and Strategies

35.1 Parathyroid Disease Treatment Market In 2029 - Countries Offering Most New Opportunities
35.2 Parathyroid Disease Treatment Market In 2029 - Segments Offering Most New Opportunities
35.3 Parathyroid Disease Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer